nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—Cholesterol Biosynthesis—HMGCR—type 2 diabetes mellitus	0.0146	0.0699	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—ACACA—type 2 diabetes mellitus	0.0127	0.0607	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—NCOA6—type 2 diabetes mellitus	0.0115	0.055	CbGpPWpGaD
Ibandronate—FDPS—Cholesterol biosynthesis—HMGCR—type 2 diabetes mellitus	0.0107	0.0514	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—ACACA—type 2 diabetes mellitus	0.0101	0.0484	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA6—type 2 diabetes mellitus	0.00916	0.0439	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—ACACA—type 2 diabetes mellitus	0.00818	0.0392	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—SREBF1—type 2 diabetes mellitus	0.00684	0.0328	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—HMGCR—type 2 diabetes mellitus	0.00665	0.0319	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PRKAA1—type 2 diabetes mellitus	0.00572	0.0274	CbGpPWpGaD
Ibandronate—FDPS—islet of Langerhans—type 2 diabetes mellitus	0.00568	0.175	CbGeAlD
Ibandronate—FDPS—SREBP signalling—RBP4—type 2 diabetes mellitus	0.00553	0.0265	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—SREBF1—type 2 diabetes mellitus	0.00546	0.0262	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—HMGCR—type 2 diabetes mellitus	0.00531	0.0254	CbGpPWpGaD
Ibandronate—FDPS—nephron tubule—type 2 diabetes mellitus	0.00457	0.141	CbGeAlD
Ibandronate—FDPS—SREBP signalling—SREBF1—type 2 diabetes mellitus	0.00442	0.0212	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—HMGCR—type 2 diabetes mellitus	0.0043	0.0206	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—PPARA—type 2 diabetes mellitus	0.00411	0.0197	CbGpPWpGaD
Ibandronate—FDPS—cardiovascular system—type 2 diabetes mellitus	0.00411	0.127	CbGeAlD
Ibandronate—FDPS—kidney—type 2 diabetes mellitus	0.00402	0.124	CbGeAlD
Ibandronate—FDPS—pancreas—type 2 diabetes mellitus	0.00399	0.123	CbGeAlD
Ibandronate—FDPS—cortex of kidney—type 2 diabetes mellitus	0.00391	0.121	CbGeAlD
Ibandronate—FDPS—adipose tissue—type 2 diabetes mellitus	0.00362	0.112	CbGeAlD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—type 2 diabetes mellitus	0.00328	0.0157	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SIRT1—type 2 diabetes mellitus	0.0032	0.0153	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—LPL—type 2 diabetes mellitus	0.00301	0.0144	CbGpPWpGaD
Ibandronate—FDPS—liver—type 2 diabetes mellitus	0.00254	0.0783	CbGeAlD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.00221	0.0106	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PPARG—type 2 diabetes mellitus	0.0022	0.0105	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—INS—type 2 diabetes mellitus	0.00215	0.0103	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.00209	0.01	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.00163	0.0078	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.00159	0.0076	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.00151	0.00725	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.00151	0.00725	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.00151	0.00725	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.00137	0.00658	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.00135	0.00647	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	0.00115	0.0055	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	0.00115	0.0055	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—BHMT—type 2 diabetes mellitus	0.00113	0.00539	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PTGDS—type 2 diabetes mellitus	0.000983	0.00471	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AANAT—type 2 diabetes mellitus	0.000983	0.00471	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000935	0.00448	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CDO1—type 2 diabetes mellitus	0.000932	0.00447	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GPD2—type 2 diabetes mellitus	0.000932	0.00447	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000911	0.00437	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000906	0.00434	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AK1—type 2 diabetes mellitus	0.000889	0.00426	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000879	0.00421	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—AKT1—type 2 diabetes mellitus	0.000868	0.00416	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000821	0.00393	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MAT1A—type 2 diabetes mellitus	0.000821	0.00393	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000817	0.00392	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000802	0.00384	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.000795	0.00381	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000793	0.0038	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ND1—type 2 diabetes mellitus	0.000793	0.0038	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ENPP1—type 2 diabetes mellitus	0.000793	0.0038	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HBA2—type 2 diabetes mellitus	0.000793	0.0038	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—G6PC—type 2 diabetes mellitus	0.000793	0.0038	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GCGR—type 2 diabetes mellitus	0.000768	0.00368	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000739	0.00354	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—OXCT1—type 2 diabetes mellitus	0.000725	0.00347	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYTB—type 2 diabetes mellitus	0.000725	0.00347	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000707	0.00339	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ACACA—type 2 diabetes mellitus	0.000674	0.00323	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000674	0.00323	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—STAR—type 2 diabetes mellitus	0.000674	0.00323	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CBS—type 2 diabetes mellitus	0.000646	0.0031	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ABCC8—type 2 diabetes mellitus	0.000646	0.0031	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—COX2—type 2 diabetes mellitus	0.000622	0.00298	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000622	0.00298	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NCOA6—type 2 diabetes mellitus	0.000611	0.00293	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000611	0.00293	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UCP2—type 2 diabetes mellitus	0.000601	0.00288	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UCP3—type 2 diabetes mellitus	0.000601	0.00288	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000601	0.00288	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000582	0.00279	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PCK1—type 2 diabetes mellitus	0.000565	0.00271	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000556	0.00267	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000543	0.0026	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HK1—type 2 diabetes mellitus	0.000529	0.00253	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000528	0.00253	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GCKR—type 2 diabetes mellitus	0.000511	0.00245	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LPA—type 2 diabetes mellitus	0.000511	0.00245	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000511	0.00245	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000511	0.00245	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000491	0.00235	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALDOB—type 2 diabetes mellitus	0.00049	0.00235	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000476	0.00228	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000466	0.00223	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000461	0.00221	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GLP1R—type 2 diabetes mellitus	0.000455	0.00218	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000425	0.00204	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CPT1A—type 2 diabetes mellitus	0.000416	0.002	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MTR—type 2 diabetes mellitus	0.000416	0.002	CbGpPWpGaD
Ibandronate—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000411	0.000542	CcSEcCtD
Ibandronate—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00041	0.000541	CcSEcCtD
Ibandronate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000409	0.00054	CcSEcCtD
Ibandronate—Myalgia—Metformin—type 2 diabetes mellitus	0.000409	0.000539	CcSEcCtD
Ibandronate—Chest pain—Metformin—type 2 diabetes mellitus	0.000409	0.000539	CcSEcCtD
Ibandronate—Malaise—Irbesartan—type 2 diabetes mellitus	0.000409	0.000539	CcSEcCtD
Ibandronate—FDPS—Metabolism—NAMPT—type 2 diabetes mellitus	0.000408	0.00196	CbGpPWpGaD
Ibandronate—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000407	0.000537	CcSEcCtD
Ibandronate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000407	0.000536	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000406	0.000535	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000406	0.00195	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LIPC—type 2 diabetes mellitus	0.000406	0.00194	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HBA1—type 2 diabetes mellitus	0.000406	0.00194	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GCK—type 2 diabetes mellitus	0.000406	0.00194	CbGpPWpGaD
Ibandronate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000404	0.000533	CcSEcCtD
Ibandronate—Discomfort—Metformin—type 2 diabetes mellitus	0.000404	0.000533	CcSEcCtD
Ibandronate—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000404	0.000532	CcSEcCtD
Ibandronate—FDPS—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000403	0.00193	CbGpPWpGaD
Ibandronate—Nausea—Glipizide—type 2 diabetes mellitus	0.000403	0.000531	CcSEcCtD
Ibandronate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000402	0.00053	CcSEcCtD
Ibandronate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000401	0.000529	CcSEcCtD
Ibandronate—Pain—Gliclazide—type 2 diabetes mellitus	0.000401	0.000528	CcSEcCtD
Ibandronate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000401	0.000528	CcSEcCtD
Ibandronate—Rash—Glimepiride—type 2 diabetes mellitus	0.000399	0.000526	CcSEcCtD
Ibandronate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000398	0.000525	CcSEcCtD
Ibandronate—Risedronate—PTGS2—type 2 diabetes mellitus	0.000398	1	CrCbGaD
Ibandronate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000398	0.000524	CcSEcCtD
Ibandronate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000397	0.000524	CcSEcCtD
Ibandronate—Headache—Glimepiride—type 2 diabetes mellitus	0.000396	0.000522	CcSEcCtD
Ibandronate—FDPS—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000396	0.0019	CbGpPWpGaD
Ibandronate—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000396	0.000522	CcSEcCtD
Ibandronate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000395	0.000521	CcSEcCtD
Ibandronate—Anaemia—Losartan—type 2 diabetes mellitus	0.000394	0.00052	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000392	0.000517	CcSEcCtD
Ibandronate—FDPS—Metabolism—CETP—type 2 diabetes mellitus	0.000392	0.00188	CbGpPWpGaD
Ibandronate—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000391	0.000516	CcSEcCtD
Ibandronate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00039	0.000515	CcSEcCtD
Ibandronate—Angioedema—Losartan—type 2 diabetes mellitus	0.00039	0.000514	CcSEcCtD
Ibandronate—Infection—Metformin—type 2 diabetes mellitus	0.000389	0.000513	CcSEcCtD
Ibandronate—Insomnia—Valsartan—type 2 diabetes mellitus	0.000389	0.000513	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000387	0.000511	CcSEcCtD
Ibandronate—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000386	0.00051	CcSEcCtD
Ibandronate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000386	0.000509	CcSEcCtD
Ibandronate—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000386	0.000509	CcSEcCtD
Ibandronate—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000386	0.000509	CcSEcCtD
Ibandronate—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000386	0.000509	CcSEcCtD
Ibandronate—Shock—Metformin—type 2 diabetes mellitus	0.000386	0.000508	CcSEcCtD
Ibandronate—Insomnia—Orlistat—type 2 diabetes mellitus	0.000385	0.000507	CcSEcCtD
Ibandronate—Malaise—Losartan—type 2 diabetes mellitus	0.000385	0.000507	CcSEcCtD
Ibandronate—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000384	0.000507	CcSEcCtD
Ibandronate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000384	0.000507	CcSEcCtD
Ibandronate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000384	0.000507	CcSEcCtD
Ibandronate—Vertigo—Losartan—type 2 diabetes mellitus	0.000383	0.000505	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000383	0.000505	CcSEcCtD
Ibandronate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000383	0.000505	CcSEcCtD
Ibandronate—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000382	0.000503	CcSEcCtD
Ibandronate—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000381	0.000503	CcSEcCtD
Ibandronate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000381	0.000502	CcSEcCtD
Ibandronate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000379	0.0005	CcSEcCtD
Ibandronate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000379	0.0005	CcSEcCtD
Ibandronate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000379	0.000499	CcSEcCtD
Ibandronate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000379	0.000499	CcSEcCtD
Ibandronate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000377	0.000498	CcSEcCtD
Ibandronate—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000377	0.000497	CcSEcCtD
Ibandronate—Palpitations—Losartan—type 2 diabetes mellitus	0.000377	0.000497	CcSEcCtD
Ibandronate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000376	0.000495	CcSEcCtD
Ibandronate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000375	0.000494	CcSEcCtD
Ibandronate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000374	0.000494	CcSEcCtD
Ibandronate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000374	0.000493	CcSEcCtD
Ibandronate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000374	0.000493	CcSEcCtD
Ibandronate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000372	0.000491	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000372	0.00049	CcSEcCtD
Ibandronate—Alopecia—Ramipril—type 2 diabetes mellitus	0.000371	0.000489	CcSEcCtD
Ibandronate—Fatigue—Valsartan—type 2 diabetes mellitus	0.000371	0.000489	CcSEcCtD
Ibandronate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00037	0.000488	CcSEcCtD
Ibandronate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00037	0.000488	CcSEcCtD
Ibandronate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00037	0.000488	CcSEcCtD
Ibandronate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00037	0.000487	CcSEcCtD
Ibandronate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000369	0.000487	CcSEcCtD
Ibandronate—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000368	0.000485	CcSEcCtD
Ibandronate—Constipation—Valsartan—type 2 diabetes mellitus	0.000368	0.000485	CcSEcCtD
Ibandronate—Infection—Irbesartan—type 2 diabetes mellitus	0.000367	0.000484	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000367	0.000484	CcSEcCtD
Ibandronate—Fatigue—Orlistat—type 2 diabetes mellitus	0.000367	0.000483	CcSEcCtD
Ibandronate—Erythema—Ramipril—type 2 diabetes mellitus	0.000366	0.000482	CcSEcCtD
Ibandronate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000366	0.000482	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000365	0.00175	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SNAP25—type 2 diabetes mellitus	0.000364	0.00174	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PSMD6—type 2 diabetes mellitus	0.000364	0.00174	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SREBF1—type 2 diabetes mellitus	0.000364	0.00174	CbGpPWpGaD
Ibandronate—Shock—Irbesartan—type 2 diabetes mellitus	0.000364	0.00048	CcSEcCtD
Ibandronate—Pain—Orlistat—type 2 diabetes mellitus	0.000364	0.000479	CcSEcCtD
Ibandronate—Myalgia—Losartan—type 2 diabetes mellitus	0.000363	0.000479	CcSEcCtD
Ibandronate—Chest pain—Losartan—type 2 diabetes mellitus	0.000363	0.000479	CcSEcCtD
Ibandronate—Arthralgia—Losartan—type 2 diabetes mellitus	0.000363	0.000479	CcSEcCtD
Ibandronate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000363	0.000478	CcSEcCtD
Ibandronate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000363	0.000478	CcSEcCtD
Ibandronate—Anxiety—Losartan—type 2 diabetes mellitus	0.000362	0.000477	CcSEcCtD
Ibandronate—Rash—Bromocriptine—type 2 diabetes mellitus	0.00036	0.000474	CcSEcCtD
Ibandronate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000359	0.000474	CcSEcCtD
Ibandronate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000359	0.000474	CcSEcCtD
Ibandronate—Discomfort—Losartan—type 2 diabetes mellitus	0.000359	0.000473	CcSEcCtD
Ibandronate—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000358	0.000472	CcSEcCtD
Ibandronate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000358	0.000471	CcSEcCtD
Ibandronate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000358	0.000471	CcSEcCtD
Ibandronate—FDPS—Metabolism—CTGF—type 2 diabetes mellitus	0.000357	0.00171	CbGpPWpGaD
Ibandronate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000357	0.000471	CcSEcCtD
Ibandronate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000357	0.000471	CcSEcCtD
Ibandronate—Dry mouth—Losartan—type 2 diabetes mellitus	0.000355	0.000468	CcSEcCtD
Ibandronate—FDPS—Metabolism—HMGCR—type 2 diabetes mellitus	0.000354	0.0017	CbGpPWpGaD
Ibandronate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000352	0.000464	CcSEcCtD
Ibandronate—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000352	0.000464	CcSEcCtD
Ibandronate—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000352	0.000464	CcSEcCtD
Ibandronate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00035	0.000462	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000349	0.00167	CbGpPWpGaD
Ibandronate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000348	0.000459	CcSEcCtD
Ibandronate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000348	0.000458	CcSEcCtD
Ibandronate—FDPS—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000347	0.00166	CbGpPWpGaD
Ibandronate—Infection—Losartan—type 2 diabetes mellitus	0.000346	0.000456	CcSEcCtD
Ibandronate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000345	0.000455	CcSEcCtD
Ibandronate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000345	0.000455	CcSEcCtD
Ibandronate—Shock—Losartan—type 2 diabetes mellitus	0.000342	0.000451	CcSEcCtD
Ibandronate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000342	0.000451	CcSEcCtD
Ibandronate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000341	0.00045	CcSEcCtD
Ibandronate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000341	0.000449	CcSEcCtD
Ibandronate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00034	0.000449	CcSEcCtD
Ibandronate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000339	0.000447	CcSEcCtD
Ibandronate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000339	0.000447	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000338	0.000446	CcSEcCtD
Ibandronate—Fatigue—Metformin—type 2 diabetes mellitus	0.000338	0.000445	CcSEcCtD
Ibandronate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000338	0.000445	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000337	0.000444	CcSEcCtD
Ibandronate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000336	0.000444	CcSEcCtD
Ibandronate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000336	0.000443	CcSEcCtD
Ibandronate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000336	0.000443	CcSEcCtD
Ibandronate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000336	0.000443	CcSEcCtD
Ibandronate—Constipation—Metformin—type 2 diabetes mellitus	0.000335	0.000442	CcSEcCtD
Ibandronate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000334	0.000441	CcSEcCtD
Ibandronate—FDPS—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000333	0.0016	CbGpPWpGaD
Ibandronate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000332	0.000438	CcSEcCtD
Ibandronate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000332	0.000437	CcSEcCtD
Ibandronate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000331	0.000437	CcSEcCtD
Ibandronate—Malaise—Ramipril—type 2 diabetes mellitus	0.00033	0.000435	CcSEcCtD
Ibandronate—FDPS—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000329	0.00158	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000329	0.00158	CbGpPWpGaD
Ibandronate—Rash—Glyburide—type 2 diabetes mellitus	0.000329	0.000434	CcSEcCtD
Ibandronate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000329	0.000433	CcSEcCtD
Ibandronate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000329	0.000433	CcSEcCtD
Ibandronate—Headache—Glyburide—type 2 diabetes mellitus	0.000327	0.000431	CcSEcCtD
Ibandronate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000326	0.000429	CcSEcCtD
Ibandronate—Palpitations—Ramipril—type 2 diabetes mellitus	0.000323	0.000426	CcSEcCtD
Ibandronate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000323	0.000426	CcSEcCtD
Ibandronate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000322	0.000424	CcSEcCtD
Ibandronate—FDPS—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000321	0.00154	CbGpPWpGaD
Ibandronate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000321	0.000423	CcSEcCtD
Ibandronate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00032	0.000423	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.000319	0.00153	CbGpPWpGaD
Ibandronate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000319	0.000421	CcSEcCtD
Ibandronate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000319	0.00042	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000317	0.000418	CcSEcCtD
Ibandronate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000317	0.000418	CcSEcCtD
Ibandronate—Pain—Irbesartan—type 2 diabetes mellitus	0.000316	0.000417	CcSEcCtD
Ibandronate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000316	0.000417	CcSEcCtD
Ibandronate—FDPS—Metabolism—GCG—type 2 diabetes mellitus	0.000316	0.00151	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000316	0.00151	CbGpPWpGaD
Ibandronate—Insomnia—Losartan—type 2 diabetes mellitus	0.000315	0.000415	CcSEcCtD
Ibandronate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000313	0.000413	CcSEcCtD
Ibandronate—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000313	0.000412	CcSEcCtD
Ibandronate—Urticaria—Metformin—type 2 diabetes mellitus	0.000311	0.00041	CcSEcCtD
Ibandronate—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000311	0.00041	CcSEcCtD
Ibandronate—Chest pain—Ramipril—type 2 diabetes mellitus	0.000311	0.00041	CcSEcCtD
Ibandronate—Myalgia—Ramipril—type 2 diabetes mellitus	0.000311	0.00041	CcSEcCtD
Ibandronate—Anxiety—Ramipril—type 2 diabetes mellitus	0.00031	0.000409	CcSEcCtD
Ibandronate—Nausea—Glyburide—type 2 diabetes mellitus	0.00031	0.000409	CcSEcCtD
Ibandronate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00031	0.000408	CcSEcCtD
Ibandronate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00031	0.000408	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000309	0.000408	CcSEcCtD
Ibandronate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000309	0.000407	CcSEcCtD
Ibandronate—Discomfort—Ramipril—type 2 diabetes mellitus	0.000308	0.000406	CcSEcCtD
Ibandronate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000306	0.000404	CcSEcCtD
Ibandronate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000305	0.000402	CcSEcCtD
Ibandronate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000305	0.000402	CcSEcCtD
Ibandronate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000304	0.000401	CcSEcCtD
Ibandronate—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000304	0.000401	CcSEcCtD
Ibandronate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000303	0.000399	CcSEcCtD
Ibandronate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000302	0.000399	CcSEcCtD
Ibandronate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000301	0.000397	CcSEcCtD
Ibandronate—Fatigue—Losartan—type 2 diabetes mellitus	0.0003	0.000396	CcSEcCtD
Ibandronate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000298	0.000393	CcSEcCtD
Ibandronate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000298	0.000393	CcSEcCtD
Ibandronate—Pain—Losartan—type 2 diabetes mellitus	0.000298	0.000392	CcSEcCtD
Ibandronate—Constipation—Losartan—type 2 diabetes mellitus	0.000298	0.000392	CcSEcCtD
Ibandronate—Rash—Gliclazide—type 2 diabetes mellitus	0.000295	0.000389	CcSEcCtD
Ibandronate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000295	0.000389	CcSEcCtD
Ibandronate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000294	0.000388	CcSEcCtD
Ibandronate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000294	0.000387	CcSEcCtD
Ibandronate—Shock—Ramipril—type 2 diabetes mellitus	0.000294	0.000387	CcSEcCtD
Ibandronate—Headache—Gliclazide—type 2 diabetes mellitus	0.000293	0.000387	CcSEcCtD
Ibandronate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000293	0.000386	CcSEcCtD
Ibandronate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000292	0.000385	CcSEcCtD
Ibandronate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000292	0.000385	CcSEcCtD
Ibandronate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000291	0.000384	CcSEcCtD
Ibandronate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00029	0.000382	CcSEcCtD
Ibandronate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000289	0.00038	CcSEcCtD
Ibandronate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000287	0.000378	CcSEcCtD
Ibandronate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000285	0.000375	CcSEcCtD
Ibandronate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000285	0.000375	CcSEcCtD
Ibandronate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000281	0.000371	CcSEcCtD
Ibandronate—Asthenia—Metformin—type 2 diabetes mellitus	0.000281	0.000371	CcSEcCtD
Ibandronate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000278	0.000367	CcSEcCtD
Ibandronate—Pruritus—Metformin—type 2 diabetes mellitus	0.000277	0.000366	CcSEcCtD
Ibandronate—Urticaria—Losartan—type 2 diabetes mellitus	0.000277	0.000365	CcSEcCtD
Ibandronate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000275	0.000363	CcSEcCtD
Ibandronate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000275	0.000363	CcSEcCtD
Ibandronate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000274	0.000361	CcSEcCtD
Ibandronate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000272	0.000359	CcSEcCtD
Ibandronate—FDPS—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000272	0.0013	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GNB3—type 2 diabetes mellitus	0.000272	0.0013	CbGpPWpGaD
Ibandronate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000272	0.000358	CcSEcCtD
Ibandronate—Rash—Valsartan—type 2 diabetes mellitus	0.000271	0.000358	CcSEcCtD
Ibandronate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000271	0.000357	CcSEcCtD
Ibandronate—FDPS—Metabolism—HMOX1—type 2 diabetes mellitus	0.000271	0.0013	CbGpPWpGaD
Ibandronate—Vomiting—Orlistat—type 2 diabetes mellitus	0.00027	0.000356	CcSEcCtD
Ibandronate—Insomnia—Ramipril—type 2 diabetes mellitus	0.00027	0.000356	CcSEcCtD
Ibandronate—Headache—Valsartan—type 2 diabetes mellitus	0.00027	0.000355	CcSEcCtD
Ibandronate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000268	0.000354	CcSEcCtD
Ibandronate—Rash—Orlistat—type 2 diabetes mellitus	0.000268	0.000354	CcSEcCtD
Ibandronate—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000268	0.000353	CcSEcCtD
Ibandronate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000268	0.000353	CcSEcCtD
Ibandronate—FDPS—Metabolism—CAT—type 2 diabetes mellitus	0.000267	0.00128	CbGpPWpGaD
Ibandronate—Headache—Orlistat—type 2 diabetes mellitus	0.000266	0.000351	CcSEcCtD
Ibandronate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000265	0.00035	CcSEcCtD
Ibandronate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000263	0.000346	CcSEcCtD
Ibandronate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000262	0.000345	CcSEcCtD
Ibandronate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000259	0.000342	CcSEcCtD
Ibandronate—FDPS—Metabolism—APOB—type 2 diabetes mellitus	0.000259	0.00124	CbGpPWpGaD
Ibandronate—Dizziness—Metformin—type 2 diabetes mellitus	0.000259	0.000342	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000258	0.00034	CcSEcCtD
Ibandronate—Fatigue—Ramipril—type 2 diabetes mellitus	0.000257	0.000339	CcSEcCtD
Ibandronate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000256	0.000338	CcSEcCtD
Ibandronate—Nausea—Valsartan—type 2 diabetes mellitus	0.000256	0.000337	CcSEcCtD
Ibandronate—Constipation—Ramipril—type 2 diabetes mellitus	0.000255	0.000336	CcSEcCtD
Ibandronate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000253	0.000334	CcSEcCtD
Ibandronate—Nausea—Orlistat—type 2 diabetes mellitus	0.000253	0.000333	CcSEcCtD
Ibandronate—FDPS—Metabolism—GSTM1—type 2 diabetes mellitus	0.000252	0.00121	CbGpPWpGaD
Ibandronate—Asthenia—Losartan—type 2 diabetes mellitus	0.00025	0.000329	CcSEcCtD
Ibandronate—Vomiting—Metformin—type 2 diabetes mellitus	0.000249	0.000329	CcSEcCtD
Ibandronate—FDPS—Metabolism—LPL—type 2 diabetes mellitus	0.000248	0.00119	CbGpPWpGaD
Ibandronate—Rash—Metformin—type 2 diabetes mellitus	0.000247	0.000326	CcSEcCtD
Ibandronate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000247	0.000325	CcSEcCtD
Ibandronate—Pruritus—Losartan—type 2 diabetes mellitus	0.000246	0.000325	CcSEcCtD
Ibandronate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000246	0.000324	CcSEcCtD
Ibandronate—Headache—Metformin—type 2 diabetes mellitus	0.000246	0.000324	CcSEcCtD
Ibandronate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000245	0.000322	CcSEcCtD
Ibandronate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000244	0.000322	CcSEcCtD
Ibandronate—FDPS—Metabolism—ADCY5—type 2 diabetes mellitus	0.000242	0.00116	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GPX1—type 2 diabetes mellitus	0.000242	0.00116	CbGpPWpGaD
Ibandronate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000238	0.000314	CcSEcCtD
Ibandronate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000237	0.000313	CcSEcCtD
Ibandronate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000236	0.000311	CcSEcCtD
Ibandronate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000236	0.000311	CcSEcCtD
Ibandronate—FDPS—Metabolism—CD36—type 2 diabetes mellitus	0.000235	0.00113	CbGpPWpGaD
Ibandronate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000235	0.00031	CcSEcCtD
Ibandronate—Rash—Irbesartan—type 2 diabetes mellitus	0.000233	0.000307	CcSEcCtD
Ibandronate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000233	0.000307	CcSEcCtD
Ibandronate—Nausea—Metformin—type 2 diabetes mellitus	0.000233	0.000307	CcSEcCtD
Ibandronate—FDPS—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000232	0.00111	CbGpPWpGaD
Ibandronate—Headache—Irbesartan—type 2 diabetes mellitus	0.000232	0.000305	CcSEcCtD
Ibandronate—Dizziness—Losartan—type 2 diabetes mellitus	0.00023	0.000303	CcSEcCtD
Ibandronate—FDPS—Metabolism—MTHFR—type 2 diabetes mellitus	0.000223	0.00107	CbGpPWpGaD
Ibandronate—Vomiting—Losartan—type 2 diabetes mellitus	0.000221	0.000292	CcSEcCtD
Ibandronate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00022	0.00029	CcSEcCtD
Ibandronate—Nausea—Irbesartan—type 2 diabetes mellitus	0.00022	0.00029	CcSEcCtD
Ibandronate—Rash—Losartan—type 2 diabetes mellitus	0.000219	0.000289	CcSEcCtD
Ibandronate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000219	0.000289	CcSEcCtD
Ibandronate—FDPS—Metabolism—PPARA—type 2 diabetes mellitus	0.000219	0.00105	CbGpPWpGaD
Ibandronate—Headache—Losartan—type 2 diabetes mellitus	0.000218	0.000287	CcSEcCtD
Ibandronate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000214	0.000282	CcSEcCtD
Ibandronate—FDPS—Metabolism—AGT—type 2 diabetes mellitus	0.000212	0.00102	CbGpPWpGaD
Ibandronate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000211	0.000278	CcSEcCtD
Ibandronate—FDPS—Metabolism—CALM1—type 2 diabetes mellitus	0.000208	0.000998	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOE—type 2 diabetes mellitus	0.000208	0.000995	CbGpPWpGaD
Ibandronate—Nausea—Losartan—type 2 diabetes mellitus	0.000207	0.000273	CcSEcCtD
Ibandronate—FDPS—Metabolism—APOA1—type 2 diabetes mellitus	0.000205	0.000983	CbGpPWpGaD
Ibandronate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000204	0.000269	CcSEcCtD
Ibandronate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000197	0.00026	CcSEcCtD
Ibandronate—Vomiting—Ramipril—type 2 diabetes mellitus	0.00019	0.00025	CcSEcCtD
Ibandronate—Rash—Ramipril—type 2 diabetes mellitus	0.000188	0.000248	CcSEcCtD
Ibandronate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000188	0.000248	CcSEcCtD
Ibandronate—Headache—Ramipril—type 2 diabetes mellitus	0.000187	0.000247	CcSEcCtD
Ibandronate—FDPS—Metabolism—PPARG—type 2 diabetes mellitus	0.000181	0.000867	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—INS—type 2 diabetes mellitus	0.000177	0.00085	CbGpPWpGaD
Ibandronate—Nausea—Ramipril—type 2 diabetes mellitus	0.000177	0.000234	CcSEcCtD
Ibandronate—FDPS—Metabolism—ALB—type 2 diabetes mellitus	0.000163	0.000779	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NOS3—type 2 diabetes mellitus	0.000156	0.000745	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000156	0.000745	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PTGS2—type 2 diabetes mellitus	0.000142	0.000682	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AKT1—type 2 diabetes mellitus	7.15e-05	0.000343	CbGpPWpGaD
